EVENTS
Wednesday, June 5, 2019
STOCK INFORMATION
NASDAQEVFM
PRESS RELEASES
Jun 10, 2019

Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, and PDL BioPharma, Inc. (Nasdaq: PDLI) (PDL) today announced the closing of the second tranche for $50...

May 14, 2019

Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, announced today that its Chief Executive Officer, Saundra Pelletier, will present at the 2019 RBC Capital...

May 7, 2019

Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a clinical stage biopharmaceutical company, today reported financial results for the three- month period ended March 31, 2019....

Apr 30, 2019

Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a conference call to discuss financial results and business highlights for the first quarter ended March 31, 2019, as follows: Date Tuesday, May...

Apr 23, 2019

Evofem Biosciences, Inc. (NASDAQ: EVFM) ("Evofem"), a clinical stage biopharmaceutical company, today announced the completion of patient enrollment in AMPREVENCE, the Phase 2b clinical trial...

Read More